Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response from a multicentric Italian retrospective study

Crocetti L, de Baére T, Pereira PL, Tarantino FP (2020) CIRSE standards of practice on thermal ablation of liver tumours. Cardiovasc Intervent Radiol 43(7):951–962. https://doi.org/10.1007/s00270-020-02471-z

Article  PubMed  Google Scholar 

Harari CM, Magagna M, Bedoya M, Lee FT Jr, Lubner MG, Hinshaw JL, Ziemlewicz T, Brace CL (2016) Microwave ablation: comparison of simultaneous and sequential activation of multiple antennas in liver model systems. Radiology 278(1):95–103. https://doi.org/10.1148/radiol.2015142151

Article  PubMed  Google Scholar 

Andresciani F, Pacella G, Vertulli D, Altomare C, Bitonti MT, Bruno A, Cea L, Faiella E, BeomonteZobel B, Grasso RF (2023) Microwave ablation using two simultaneous antennas for the treatment of liver malignant lesions: a 3 year single-Centre experience. Int J Hyperth 40(1):2163309. https://doi.org/10.1080/02656736.2022.2163309

Article  CAS  Google Scholar 

Garnon J, Delmas L, De Marini P, Dalili D, Koch G, Auloge P, Cazzato RL, Gangi A (2021) Triple-antenna microwave ablation with repositioning for the creation of a reliable 6-cm ablation zone in the liver. Cardiovasc Intervent Radiol 44(8):1291–1295. https://doi.org/10.1007/s00270-021-02854-w

Article  PubMed  Google Scholar 

Cazzato RL, De Marini P, Leclerc L, Dalili D, Koch G, Rao P, Auloge P, Garnon J, Gangi A (2020) Large nearly spherical ablation zones are achieved with simultaneous multi-antenna microwave ablation applied to treat liver tumours. Eur Radiol 30(2):971–975. https://doi.org/10.1007/s00330-019-06431-1

Article  PubMed  Google Scholar 

Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK (1998) Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 227(4):559–565. https://doi.org/10.1097/00000658-199804000-00018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen P, Fleming S, Westcott C, Challa V (2003) Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: effect of the Pringle maneuver. J Surg Oncol 83(1):36–41. https://doi.org/10.1002/jso.10235

Article  PubMed  Google Scholar 

Poch FGM, Neizert CA, Gemeinhardt O, Geyer B, Eminger K, Rieder C, Niehues SM, Vahldiek J, Thieme SF, Lehmann KS (2018) Intermittent Pringle maneuver may be beneficial for radiofrequency ablations in situations with tumor-vessel proximity. Innov Surg Sci 3(4):245–251. https://doi.org/10.1515/iss-2018-0008

Article  PubMed  PubMed Central  Google Scholar 

Nakai M, Sato M, Sahara S, Kawai N, Tanihata H, Kimura M, Terada M (2007) Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol 13(20):2841–2845. https://doi.org/10.3748/wjg.v13.i20.2841

Article  PubMed  PubMed Central  Google Scholar 

Subrt Z, Ferko A, Hoffmann P, Tycová V, Ryska M, Raupach J, Chovanec V, Dvorák P (2008) Temporary liver blood-outflow occlusion increases effectiveness of radiofrequency ablation: an experimental study on pigs. Eur J Surg Oncol 34(3):346–352. https://doi.org/10.1016/j.ejso.2006.11.023

Article  CAS  PubMed  Google Scholar 

Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchianò A, Fornari F, Quaretti P, Tolla GD, Ambrosi C, Mazzaferro V, Blum HE, Bartolozzi C (2000) Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217(1):119–126. https://doi.org/10.1148/radiology.217.1.r00se02119

Article  CAS  PubMed  Google Scholar 

Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K (2002) Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 95(11):2353–2360. https://doi.org/10.1002/cncr.10966

Article  PubMed  Google Scholar 

Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, Yokoyama Y, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Terai S, Sakaida I, Okita K (2005) Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 40(2):171–178. https://doi.org/10.1007/s00535-004-1516-5

Article  PubMed  Google Scholar 

Iezzi R, Cesario V, Siciliani L, Campanale M, De Gaetano AM, Siciliano M, Agnes S, Giuliante F, Grieco A, Pompili M, Rapaccini GL, Gasbarrini A, Bonomo L (2013) HepatoCATT group for the multidisciplinary management of HCC. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). Radiol Med 118(4):555–569. https://doi.org/10.1007/s11547-012-0914-7

Article  CAS  PubMed  Google Scholar 

Lucatelli P, Argirò R, Crocetti L, Rocco B, Bozzi E, Gasparrini F, Tanzilli A, Catalano C, Iezzi R (2022) Percutaneous thermal segmentectomy: proof of concept. Cardiovasc Intervent Radiol 45(5):665–676. https://doi.org/10.1007/s00270-022-03117-y

Article  PubMed  Google Scholar 

Iezzi R, Posa A, Tanzilli A, Carchesio F, Pompili M, Manfredi R (2020) Balloon-occluded MWA (b-MWA) followed by balloon-occluded TACE (b-TACE): technical note on a new combined single-step therapy for single large HCC. Cardiovasc Intervent Radiol 43(11):1702–1707. https://doi.org/10.1007/s00270-020-02583-6

Article  PubMed  Google Scholar 

Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31–S34. https://doi.org/10.4103/sja.SJA_543_18

Article  PubMed  PubMed Central  Google Scholar 

Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60. https://doi.org/10.1055/s-0030-1247132

Article  CAS  PubMed  Google Scholar 

Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L (2016) RECIST 1.1-update and clarification: from the RECIST committee. Eur J Cancer 62:132–137. https://doi.org/10.1016/j.ejca.2016.03.081

Article  PubMed  PubMed Central  Google Scholar 

Petersson S, Sehlstedt K. Variable selection techniques for the Cox proportional hazards model: a comparative study. University of Gothenburg School of Business, Economics and Law. 2018-02-21. https://core.ac.uk/download/pdf/152600668.pdf

Lai Q, Sapisochin G, Gorgen A, Vitale A, Halazun KJ, Iesari S, Schaefer B, Bhangui P, Mennini G, Wong TCL, Uemoto S, Lin CC, Mittler J, Ikegami T, Yang Z, Frigo AC, Zheng SS, Soejima Y, Hoppe-Lotichius M, Chen CL, Kaido T, Lo CM, Rossi M, Soin AS, Finkenstedt A, Emond JC, Cillo U, Lerut JP (2021) Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant. JAMA Surg 156(9):e213112. https://doi.org/10.1001/jamasurg.2021.3112

Article  PubMed  PubMed Central  Google Scholar 

Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97(5):1253–1262. https://doi.org/10.1002/cncr.11168

Article  PubMed  Google Scholar 

Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76(3):681–693. https://doi.org/10.1016/j.jhep.2021.11.018

Article  PubMed  Google Scholar 

Veloso Gomes F, de Baère T, Verset G, Coimbra É, Tovar-Felice G, Malagari K, Bruix J (2023) Transarterial chemoembolization with anthracyclines-loaded polyethylene glycol drug eluting microspheres for the treatment of hepatocellular carcinoma: a pooled multicentric analysis of survival in 580 patients. Cardiovasc Intervent Radiol 46(4):436–446. https://doi.org/10.1007/s00270-023-03362-9

Article  PubMed  PubMed Central  Google Scholar 

Golfieri R, Bezzi M, Verset G, Fucilli F, Mosconi C, Cappelli A, Paccapelo A, Lucatelli P, Magand N, Rode A, Debaere T (2021) Balloon-occluded transarterial chemoembolization: in which size range does it perform best? A comparison of its efficacy versus conventional transarterial chemoembolization, using propensity score matching. Liver Cancer 10(5):522–534. https://doi.org/10.1159/000516613

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gwon DI, Kim GH, Chu HH, Kim JH, Ko GY, Yoon HK (2023) Local recurrence following radiological complete response in patients treated with subsegmental balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancers (Basel) 15(20):4991. https://doi.org/10.3390/cancers15204991

Article  CAS  PubMed  Google Scholar 

Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, Fowers K, Lewandowski R, Padia SA (2021) Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology 74(5):2342–2352. https://doi.org/10.1002/hep.31819

Comments (0)

No login
gif